SE0102048D0 - New Compounds - Google Patents

New Compounds

Info

Publication number
SE0102048D0
SE0102048D0 SE0102048A SE0102048A SE0102048D0 SE 0102048 D0 SE0102048 D0 SE 0102048D0 SE 0102048 A SE0102048 A SE 0102048A SE 0102048 A SE0102048 A SE 0102048A SE 0102048 D0 SE0102048 D0 SE 0102048D0
Authority
SE
Sweden
Prior art keywords
compounds
new compounds
sulfonamide
substituted
prophylaxis
Prior art date
Application number
SE0102048A
Other languages
English (en)
Inventor
Ulf Bremberg
Patrizia Caldirola
Gary Johansson
Andrew Mott
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE0102048A priority Critical patent/SE0102048D0/sv
Publication of SE0102048D0 publication Critical patent/SE0102048D0/sv
Priority to ZA200308097A priority patent/ZA200308097B/xx
Priority to PCT/SE2002/001126 priority patent/WO2002100822A1/en
Priority to US10/167,141 priority patent/US7144883B2/en
Priority to KR1020037016203A priority patent/KR100889718B1/ko
Priority to CA002445653A priority patent/CA2445653A1/en
Priority to BR0210291-9A priority patent/BR0210291A/pt
Priority to YU98003A priority patent/YU98003A/sh
Priority to NZ529032A priority patent/NZ529032A/en
Priority to CNA2005101381444A priority patent/CN1800185A/zh
Priority to JP2003503591A priority patent/JP4731114B2/ja
Priority to EP02778916A priority patent/EP1412325A1/en
Priority to AU2002309435A priority patent/AU2002309435B2/en
Priority to PL02367264A priority patent/PL367264A1/xx
Priority to IL15859002A priority patent/IL158590A0/xx
Priority to EA200400027A priority patent/EA008476B1/ru
Priority to CNB028103777A priority patent/CN100457726C/zh
Priority to CNA2008101812345A priority patent/CN101402601A/zh
Priority to MXPA03011083A priority patent/MXPA03011083A/es
Priority to KR1020097000129A priority patent/KR20090019894A/ko
Priority to KR1020087016920A priority patent/KR100888906B1/ko
Priority to NO20035496A priority patent/NO20035496D0/no
Priority to HK04109896.2A priority patent/HK1066790A1/xx
Priority to US11/509,914 priority patent/US20070066598A1/en
Priority to US11/509,989 priority patent/US20070066599A1/en
Priority to US11/510,324 priority patent/US7572787B2/en
Priority to JP2009209444A priority patent/JP2010013473A/ja
Priority to US12/781,355 priority patent/US20100222330A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE0102048A 2001-06-11 2001-06-11 New Compounds SE0102048D0 (sv)

Priority Applications (28)

Application Number Priority Date Filing Date Title
SE0102048A SE0102048D0 (sv) 2001-06-11 2001-06-11 New Compounds
KR1020087016920A KR100888906B1 (ko) 2001-06-11 2002-06-11 치환 술폰아미드 화합물, ｃｎｓ 장애, 비만 및 ⅱ 형당뇨병 치료용 약제로서의 이들의 사용 방법
AU2002309435A AU2002309435B2 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes
IL15859002A IL158590A0 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
US10/167,141 US7144883B2 (en) 2001-06-11 2002-06-11 Bicyclic sulfonamide compounds
KR1020037016203A KR100889718B1 (ko) 2001-06-11 2002-06-11 치환 술폰아미드 화합물, ｃｎｓ 장애, 비만 및 ⅱ 형당뇨병 치료용 약제로서의 이들의 사용 방법
CA002445653A CA2445653A1 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
BR0210291-9A BR0210291A (pt) 2001-06-11 2002-06-11 Compostos de sulfonamida substituìdos, processo para sua preparação e seu uso como medicamento para o tratamento de distúrbios do sistema nervoso central, obesidade e diabetes do tipo ii
YU98003A YU98003A (sh) 2001-06-11 2002-06-11 Supstituisana sulfonamidna jedinjenja, postupak za njihovu upotrebu kao leka za tretiranje poremećaja cns, gojaznosti i dijabetesa tipa ii
NZ529032A NZ529032A (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes
CNA2005101381444A CN1800185A (zh) 2001-06-11 2002-06-11 取代的磺酰胺化合物、其制备方法及其作为治疗cns疾病、肥胖和ii型糖尿病的药物的应用
JP2003503591A JP4731114B2 (ja) 2001-06-11 2002-06-11 置換スルホンアミド化合物、ｃｎｓ障害、肥満およびｉｉ型糖尿病の処置のための医薬としてのそれらの使用方法
EP02778916A EP1412325A1 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
ZA200308097A ZA200308097B (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes.
PL02367264A PL367264A1 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
PCT/SE2002/001126 WO2002100822A1 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
EA200400027A EA008476B1 (ru) 2001-06-11 2002-06-11 Замещенные сульфонамиды, способ их получения и их применение в качестве лечебного средства для лечения расстройств цнс, ожирения и диабета типа ii
CNB028103777A CN100457726C (zh) 2001-06-11 2002-06-11 取代的磺酰胺化合物、其制备方法及其作为治疗cns疾病、肥胖和ⅱ型糖尿病的药物的应用
CNA2008101812345A CN101402601A (zh) 2001-06-11 2002-06-11 取代的磺酰胺化合物、其制备方法及其作为治疗cns疾病、肥胖和ⅱ型糖尿病的药物的应用
MXPA03011083A MXPA03011083A (es) 2001-06-11 2002-06-11 Compuestos de sulfonamida sustituida, procedimiento para su preparacion, y su uso como medicamento para el tratamiento de trastornos del sistema nervioso central. obesidad y diabetes tipo ii.
KR1020097000129A KR20090019894A (ko) 2001-06-11 2002-06-11 치환 술폰아미드 화합물, ｃｎｓ 장애, 비만 및 ⅱ 형 당뇨병 치료용 약제로서의 이들의 사용 방법
NO20035496A NO20035496D0 (no) 2001-06-11 2003-12-10 Substituerte sulfonamidforbindelser, fremgangsmåte for deres anvendelse sommedikament til behandling av CNS-forstyrrelser, overvekt og typeII-diabetes
HK04109896.2A HK1066790A1 (en) 2001-06-11 2004-12-14 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
US11/509,914 US20070066598A1 (en) 2001-06-11 2006-08-25 Compounds
US11/509,989 US20070066599A1 (en) 2001-06-11 2006-08-25 New compounds
US11/510,324 US7572787B2 (en) 2001-06-11 2006-08-25 Substituted naphthalene sulfonamides
JP2009209444A JP2010013473A (ja) 2001-06-11 2009-09-10 置換スルホンアミド化合物、ｃｎｓ障害、肥満およびｉｉ型糖尿病の処置のための医薬としてのそれらの使用方法
US12/781,355 US20100222330A1 (en) 2001-06-11 2010-05-17 New Compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102048A SE0102048D0 (sv) 2001-06-11 2001-06-11 New Compounds

Publications (1)

Publication Number Publication Date
SE0102048D0 true SE0102048D0 (sv) 2001-06-11

Family

ID=20284423

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102048A SE0102048D0 (sv) 2001-06-11 2001-06-11 New Compounds

Country Status (3)

Country Link
CN (1) CN101402601A (sv)
SE (1) SE0102048D0 (sv)
ZA (1) ZA200308097B (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI754702B (zh) * 2016-12-28 2022-02-11 德商Ｕｃｂ製藥有限公司 （氮雜）吲哚－和苯並呋喃－３－磺醯胺類

Also Published As

Publication number Publication date
ZA200308097B (en) 2004-10-18
CN101402601A (zh) 2009-04-08

Similar Documents

Publication Publication Date Title
MXPA03011083A (es) Compuestos de sulfonamida sustituida, procedimiento para su preparacion, y su uso como medicamento para el tratamiento de trastornos del sistema nervioso central. obesidad y diabetes tipo ii.
MXPA03010232A (es) Compuestos de arilsulfonamida, para el tratamiento de la obesidad, de la diabetes tipo ii y de trastornos del sistema nervioso central.
EA200600975A1 (ru) Конденсированные гетероциклические соединения, применимые для лечения ожирения и расстройств центральной нервной системы
EA199900669A1 (ru) Промежуточные соединения для получения замещенных n-[аминоиминометил или аминометил)фенил]пропиламидов
EA200600048A1 (ru) Производные бензазепина, используемые для лечения заболеваний, ассоциированных с 5-ht-рецептором
DK1438310T3 (da) Beta-carbolin-derivater som PTP-inhibitorer
JO2764B1 (en) Indole derivatives or benzimidazole derivatives to modify the enzyme AKP kinase
EA200301216A1 (ru) Замещенные хинуклидинами мультициклические гетероарилы для лечения заболевания
BR0012450A (pt) Benzimidazóis substituìdos
BRPI0409109A (pt) novos compostos
NO20075781L (no) Diarylsulfone-sulfonamider og deres anvendelse
SE0303180D0 (sv) Novel compounds
SE0302232D0 (sv) Novel Compounds
MY139690A (en) Sulfonamide derivatives for the treatment of diseases.
NO20052272L (no) CCR1-antagonister for behandling av blant annet demylinerene inflamasjonssykdom
SE0403006D0 (sv) New compounds
EA200700848A1 (ru) Ингибиторы pi3-гамма-киназы для лечения анемии
DK1735296T3 (da) Materialer og fremgangsmåder til behandling af koagulationslidelser
BR0213094A (pt) Derivados de cromano como ligandos de 5-hidroxi-triptamina-6
NO20050270L (no) Nye forbindelser, deres anvendelse og fremstilling
NO20063865L (no) Heterocyklisk substituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og deres anvendelse som medikamenter
DK1456212T3 (da) 6-aminomorphinanderivater, fremgangsmåder til fremstilling heraf og disses anvendelse
BRPI0508927A (pt) compostos úteis para o tratamento de doenças
NO20060718L (no) Substituerte tiofoner og deres anvendelse
NO20065835L (no) Medikamenter som inneholder N-sulfamoyl-N'-arylpiperaziner for profylakse eller behandling av overvekt og beslektede tilstander